IBEX 35
11.044,40 +154,20 (+1,42%) Euro Stoxx 50
4.983,93 +47,08 (+0,95%) Dólar/Euro
1,0662 +0,0006 (+0,05%) Petróleo Brent
86,96 -0,04 (-0,05%) Oro
2.313,30 -33,10 (-1,41%) Bitcoin EUR
62.151,17 +191,89 (+0,31%)
Zoetis Inc. (ZTS)
Antes de la apertura:
Zoetis Inc.
10 Sylvan Way
Parsippany, NJ 07054
United States
973 822 7000
https://www.zoetis.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 14.100
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Ms. Kristin C. Peck | CEO & Director | 3,54M | 5,2M | 1971 |
| Mr. Wetteny N. Joseph | Executive VP & CFO | 1,6M | N/A | 1972 |
| Ms. Wafaa Mamilli | EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health | 1,36M | N/A | 1967 |
| Ms. Heidi C. Chen | Employee Advisor | 1,24M | N/A | 1967 |
| Dr. Robert J. Polzer Ph.D. | Executive VP and President of Research & Development | 1,18M | 54,13k | 1969 |
| Ms. Roxanne Lagano | EVP, Chief HR Officer & Global Operations, Interim General Counsel and Corporate Secretary | N/A | N/A | 1965 |
| Mr. Steven Frank | Vice President of Investor Relations | N/A | N/A | N/A |
| Mr. William Price | VP & Chief Communications Officer | N/A | N/A | N/A |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer | N/A | N/A | 1975 |
| Mr. Nick Ashton | Executive VP and President of Global Manufacturing & Supply | N/A | N/A | 1973 |
Descripción
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Gobierno corporativo
El ISS Governance QualityScore de Zoetis Inc., a día 1 de abril de 2024, es 3. Las puntuaciones base son Auditoría: 5; Tablero: 2; Derechos de los accionistas: 7; Compensación: 2.
